![]() |
市場調查報告書
商品編碼
1930137
全球疝氣修補網片市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測(2026-2034)Hernia Mesh Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
預計2025年全球疝氣修補網片市場規模將達24億美元,從2026年的25.3億美元成長至2034年的44.2億美元,預測期內複合年增長率(CAGR)為7.22%。北美預計將在2025年佔市場主導地位,市場佔有率達35.91%,這主要得益於腹腔鏡疝氣修補術的日益普及以及主要醫療器材製造商的強大市場地位。
疝氣修補網片是一種外科植入物,用於在疝氣修補手術中加固薄弱的組織。全球疝氣疾病發生率的不斷上升以及人們對網片修補術日益增長的偏好,是推動市場擴張的重要因素。
市場驅動因素
疝氣疾病發生率的上升是市場成長的主要驅動因素。根據本報告引用的數據,2019年全球新增疝氣病例達1,302萬例,其中86.3%為男性。疝氣負擔的加重促使全球手術介入次數的增加。
此外,大多數疝氣修補手術都使用網片。全球約80%的疝氣手術都使用疝氣修補網片,顯著推動了產品需求。市場參與者致力於推出技術先進的生物材料網片產品,也進一步加速了這些產品在醫院和手術中心的應用。
新冠疫情的影響
在新冠疫情期間,疝氣修補網片市場經歷了短暫的下滑,主要原因是擇期手術和非緊急手術的延遲。由於醫療機構優先處理急診,手術數量減少,導致產品需求下降。
然而,隨著外科手術的恢復,市場在接下來的幾年裡強勁復甦。疝氣修補手術量的增加以及對網片修復解決方案需求的恢復,為製造商帶來了收入的成長,從而支撐了市場的穩定和復甦。
市場趨勢
影響市場的關鍵趨勢是專注於新產品的推出。製造商正在開發具有更高機械強度、更低復發率和更強生物相容性的先進網片產品。
由於可吸收網片能夠改善臨床療效並減少併發症,其引入引起了廣泛關注。老牌企業和新進業者不斷創新,改善了患者獲得先進疝氣修補方案的機會,從而促進了整體市場成長。
限制因子
儘管成長潛力巨大,疝氣修補網片使用相關的併發症仍然是主要限制因素。這些併發症包括疝氣復發、感染、沾黏、腸阻塞和慢性疼痛。
根據本報告引用的數據,網片修補術後的疝氣復發率高達 30%。此外,對不良患者預後的擔憂促使人們尋求替代的非網片修補技術,這可能會在某些情況下限制網片的應用。
依產品劃分:
市場依產品分為生物網片和合成網片。預計到 2026 年,生物網片將佔 63.23% 的市場佔有率,這主要得益於其卓越的機械強度和較低的復發率。由於其成本效益和易得性,合成網片預計將保持穩定成長。
依類型劃分:
市場依疝氣類型分為腹股溝疝氣、股疝氣、腹壁疝氣和其他類型。由於每年進行的腹股溝疝氣手術數量眾多,腹股溝疝氣細分市場預計將佔領先地位,到 2026 年將佔 52.5% 的市場佔有率。
依最終使用者劃分:
由於疝氣手術數量的增加和先進的手術基礎設施,醫院和門診手術中心 (ASC) 細分市場預計將佔主導地位,到 2026 年將佔 72.24% 的市場佔有率。由於人們對疝氣的認識不斷提高,以及手術效率的提升,專科診所預計將穩步增長。
北美將佔市場領先地位,2025 年市場規模將達到 8.6 億美元,預計到 2026 年,美國市場規模將達到 8.8 億美元。由於疝氣修補手術中網片的使用率較高,歐洲將維持較大的市場佔有率,預計到 2026 年,德國市場規模將達到 1.6 億美元。
亞太地區預計將迎來顯著成長,這主要得益於疝氣盛行率和手術量的上升。預計到 2026 年,中國市場規模將達到 2.4 億美元,日本達到 1.4 億美元,印度達到 1 億美元。
The global hernia mesh devices market was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.53 billion in 2026 to USD 4.42 billion by 2034, registering a CAGR of 7.22% during the forecast period. North America dominated the market with a 35.91% share in 2025, supported by widespread adoption of laparoscopic hernia repair procedures and the strong presence of key medical device manufacturers.
Hernia mesh devices are surgical implants used to reinforce weakened tissue during hernia repair surgeries. The increasing global prevalence of hernia conditions and the rising preference for mesh-based surgical repairs are significantly contributing to market expansion.
Market Drivers
The rising prevalence of hernia disorders is a primary driver fueling market growth. According to data referenced in the report, global incident cases of hernia reached 13.02 million in 2019, with 86.3% of cases observed in males. The growing burden of hernia is leading to an increased number of surgical interventions worldwide.
Furthermore, a large proportion of hernia repair surgeries utilize mesh devices. Approximately 80% of hernia surgeries globally involve hernia mesh, which significantly boosts product demand. The increasing focus of market players on launching technologically advanced and biomaterial-based mesh products is further accelerating adoption across hospitals and surgical centers.
COVID-19 Impact
The hernia mesh devices market witnessed a temporary decline during the COVID-19 pandemic, primarily due to the postponement of elective and non-emergency surgeries. Healthcare facilities prioritized emergency care, leading to reduced procedural volumes and lower product demand.
However, the market recovered strongly in subsequent years with the resumption of surgical procedures. Manufacturers experienced revenue growth due to increased hernia surgeries and renewed demand for mesh-based repair solutions, supporting market stabilization and recovery.
Market Trends
A key trend shaping the market is the increasing focus on new product launches. Manufacturers are developing advanced mesh products with improved mechanical strength, reduced recurrence rates, and enhanced biocompatibility.
The introduction of biological and resorbable mesh devices has gained traction due to better clinical outcomes and reduced complications. Continuous innovation by established companies and new entrants is improving patient access to advanced hernia repair solutions and strengthening overall market growth.
Restraining Factors
Despite strong growth potential, the market faces restraints due to complications associated with hernia mesh usage. These include hernia recurrence, infection, adhesion, bowel obstruction, and chronic pain.
Data referenced in the report indicates a hernia recurrence rate of up to 30% following mesh-based surgeries. Additionally, patient concerns regarding adverse outcomes have encouraged the exploration of alternative non-mesh repair techniques, which may limit widespread adoption in certain cases.
By Product:
The market is segmented into biological mesh and synthetic mesh. The biological mesh segment dominated with a 63.23% share in 2026, driven by superior mechanical strength and reduced recurrence rates. Synthetic mesh is expected to grow steadily due to cost-effectiveness and wider availability.
By Type:
Based on hernia type, the market includes inguinal, femoral, ventral, and others. The inguinal segment led with a 52.5% share in 2026, supported by the high number of inguinal hernia surgeries performed annually.
By End User:
The hospitals & ASCs segment dominated the market with a 72.24% share in 2026, owing to the rising volume of hernia surgeries and advanced surgical infrastructure. Specialty clinics are expected to grow steadily with increasing awareness and procedural efficiency.
North America led the market with a value of USD 0.86 billion in 2025, and the U.S. market is projected to reach USD 0.88 billion by 2026. Europe holds a substantial market share due to high mesh usage rates in hernia repair surgeries, with Germany projected at USD 0.16 billion by 2026.
The Asia Pacific region is expected to grow at a significant rate, driven by rising hernia prevalence and increasing surgical volumes. By 2026, China is projected to reach USD 0.24 billion, Japan USD 0.14 billion, and India USD 0.10 billion.
Competitive Landscape
Key players operating in the market include Johnson & Johnson Services, Medtronic, BD, B. Braun SE, Baxter, W. L. Gore & Associates, Integra LifeSciences, and COOK. These companies focus on mergers, acquisitions, capacity expansion, and product innovation to strengthen their market position.
Conclusion
The global hernia mesh devices market is expected to witness steady growth from 2025 to 2034, driven by the rising prevalence of hernia conditions, increasing surgical volumes, and advancements in mesh technology. While concerns regarding complications and recurrence remain, continuous innovation, expanding adoption of biological mesh, and growing healthcare infrastructure are expected to sustain market momentum. By 2034, the market is projected to reach USD 4.42 billion, highlighting the critical role of hernia mesh devices in modern surgical care.
Segmentation By Product
By Type
By End-user
By Region